Variant report
Variant | nsv547211 |
---|---|
Chromosome Location | chr1:104890086-104911326 |
allele | n/a |
Outlinks | Ensembl   UCSC |
- TF binding region (count:0)
- CpG islands (count:0)
- Chromatin interactive region (count:0)
- LncRNA region (count:0)
- Mature miRNA region (count: 0)
- miRNA target sites (count:0)
No data |
No data |
No data |
No data |
No data |
No data |
No data |
No. | Variant name | Chromosome position | Chromatin state | Related regulatory elements | Target genes | Extended variants | Associated traits |
---|---|---|---|---|---|---|---|
1 | rs75964901 | chr1:104890658-104890659 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
2 | rs567228799 | chr1:104890667-104890668 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
3 | rs116177616 | chr1:104890668-104890669 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
4 | rs559176845 | chr1:104890673-104890674 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
5 | rs552749785 | chr1:104890722-104890723 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
6 | rs17021434 | chr1:104890742-104890743 | Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
7 | rs544843138 | chr1:104890761-104890762 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
8 | rs72996822 | chr1:104890780-104890781 | Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
9 | rs78211851 | chr1:104890806-104890807 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
10 | rs549048062 | chr1:104890809-104890810 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
11 | rs74104355 | chr1:104890821-104890822 | Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
12 | rs528053258 | chr1:104890834-104890835 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
13 | rs571591225 | chr1:104890835-104890836 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
14 | rs187941511 | chr1:104890839-104890840 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
15 | rs17021435 | chr1:104890919-104890920 | Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
16 | rs148388975 | chr1:104890938-104890939 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
17 | rs557249450 | chr1:104890951-104890952 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
18 | rs569379527 | chr1:104890952-104890953 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
19 | rs533463454 | chr1:104890969-104890970 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
20 | rs190509573 | chr1:104890979-104890980 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
21 | rs141580892 | chr1:104890991-104890992 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
22 | rs575420010 | chr1:104891018-104891019 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
23 | rs543681137 | chr1:104891032-104891033 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
24 | rs540205821 | chr1:104891037-104891038 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
25 | rs552865827 | chr1:104891067-104891068 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
26 | rs577845738 | chr1:104891084-104891085 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
27 | rs183765185 | chr1:104891085-104891086 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
28 | rs34445283 | chr1:104891092-104891093 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
29 | rs563544136 | chr1:104891208-104891209 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
30 | rs17481083 | chr1:104891246-104891247 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
31 | rs150892093 | chr1:104891277-104891278 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
32 | rs57257390 | chr1:104891303-104891304 | Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
33 | rs560934426 | chr1:104891348-104891349 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
34 | rs375528760 | chr1:104891368-104891369 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
35 | rs540277999 | chr1:104891393-104891394 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
36 | rs115094663 | chr1:104896019-104896020 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
37 | rs115259443 | chr1:104896076-104896077 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
38 | rs55986443 | chr1:104896085-104896086 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
39 | rs565016564 | chr1:104896101-104896102 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
40 | rs74920852 | chr1:104896108-104896109 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
41 | rs567867484 | chr1:104896117-104896118 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
42 | rs56900406 | chr1:104896128-104896129 | Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
43 | rs72683551 | chr1:104896139-104896140 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
44 | rs60368188 | chr1:104896141-104896142 | Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
45 | rs545417191 | chr1:104896157-104896158 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
46 | rs4409662 | chr1:104896161-104896162 | Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | mRNA abundance |
47 | rs5776726 | chr1:104896179-104896180 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
48 | rs397818362 | chr1:104896185-104896186 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
49 | rs58998214 | chr1:104896208-104896209 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
50 | rs5776727 | chr1:104896264-104896265 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
Disease | PMID | Source |
---|---|---|
Wilms tumour | 21544195 | CNVD |
Coronary Disease | 20032323 | CNVD |
Prostate cancer | 21965145 | CNVD |
Glioblastoma multiforme | 21080181 | CNVD |
Acute lymphoblastic leukemia | 20067559 | CNVD |
Stargardt''s disease | 17277736 | CNVD |
Neuroblastoma | 17897457 | CNVD |
Uveal melanoma | 21693616 | CNVD |
Cancer | 21637783 | CNVD |
Colorectal cancer | 20709793 | CNVD |
Ewing''s sarcoma | 21437220 | CNVD |
Neuroblastoma | 21484798 | CNVD |
Non-syndromic sensorineural hearing loss | 22290220 | CNVD |
Liposarcoma | 21253554 | CNVD |
Breast cancer | 21264507 | CNVD |
Acute myeloid leukemia | 16864856 | CNVD |
Astrocytoma | 17387387 | CNVD |
Cancer | 21499728 | CNVD |
Glioblastoma multiforme | 17387387 | CNVD |
Oligodendroglial tumors | 17285580 | CNVD |
Papillary thyroid carcinoma | 21436994 | CNVD |
Neuroblastoma | 17535989 | CNVD |
Pheochromocytoma | 17535989 | CNVD |
Prostate cancer | 16705090 | CNVD |
Astrocytoma | 17934521 | CNVD |
Colorectal cancer | 19359472 | CNVD |
Neuroblastoma | 18664255 | CNVD |
Monoclonal gammopathy of undetermined significance | 17077331 | CNVD |
Multiple myeloma | 17077331 | CNVD |
Gastrointestinal stromal cancer | 19259404 | CNVD |
Gastrointestinal stromal cancer | 20470368 | CNVD |
Gastrointestinal stromal cancer | 17535989 | CNVD |
Neuroblastoma | 17533364 | CNVD |
Paraganglioma | 17535989 | CNVD |
Pulmonary chondroma | 17535989 | CNVD |
Myofibroblastic sarcoma | 19369631 | CNVD |
Breast cancer | 17603634 | CNVD |
Esophageal squamous carcinoma | 21637470 | CNVD |
HIV/AIDS | 22032296 | CNVD |
Schizophrenia | 19415332 | CNVD |
Non-syndromic sensorineural hearing loss | 21030649 | CNVD |
Thoracic aortic aneurysm | 21092924 | CNVD |
T-cell prolymphocytic leukemia | 19278963 | CNVD |
Autism | 22495311 | CNVD |
Non-small cell lung cancer | 21385341 | CNVD |
Gastrointestinal stromal cancer | 16982739 | CNVD |
Chordoma | 21602918 | CNVD |
Acute lymphoblastic leukemia | 17443227 | CNVD |
Melanoma | 18172304 | CNVD |
Multiple myeloma | 16461302 | CNVD |
Cancer | 21129771 | CNVD |
Autosomal dominant nocturnal frontal lobe epilepsy | 18472482 | CNVD |
Hirschsprung''s Disease | 21712996 | CNVD |
Non-small cell lung cancer | 20864512 | CNVD |
Non-syndromic sensorineural hearing loss | 15273396 | CNVD |
Thrombocytopenia-absent radius syndrome | 21933853 | CNVD |
Psychiatric disorder | 22848183 | CNVD |
Diffuse large b-cell lymphoma | 18287131 | CNVD |
Hepatocellular carcinoma | 16750200 | CNVD |
Burkitt''s lymphoma | 18698080 | CNVD |
Breast cancer | 20409316 | CNVD |
Splenic marginal zone lymphoma | 21957467 | CNVD |
Breast cancer | 17393978 | CNVD |
Medulloblastoma | 21979893 | CNVD |
Cervical cancer | 21062161 | CNVD |
Cancer | 21183584 | CNVD |
Lung cancer | 18438408 | CNVD |
Breast cancer | 21785460 | CNVD |
Breast cancer | 21364760 | CNVD |
Rett syndrome | 21593744 | CNVD |
Prostate cancer | 16573809 | CNVD |
Breast cancer | 16608533 | CNVD |
Acute lymphoblastic leukemia | 20435627 | CNVD |
Ovarian cancer | 21720365 | CNVD |
Endometrioid adenocarcinoma | 16974079 | CNVD |
Intellectual disability | 22102821 | CNVD |
Cancer | 20164919 | CNVD |
Cancer | 22429812 | CNVD |
Malignant mesothelioma | 18160781 | CNVD |
Pleural malignant mesothelioma | 18160781 | CNVD |
Pancreatic endocrine tumor | 17639061 | CNVD |
Esophageal adenocarcinoma | 18820669 | CNVD |
small cell lung cancer | 20016488 | CNVD |
Hodgkin''s lymphoma | 17606441 | CNVD |
Glioblastoma multiforme | 21922591 | CNVD |
Autism | 17483303 | CNVD |
Intestinal disease | 21956041 | CNVD |
Carcinoma ex pleomorphic adenoma | 18828159 | CNVD |
Schizophrenia | 17879154 | CNVD |
Mental retardation | 17124404 | CNVD |
Intestinal disease | 17828263 | CNVD |
lymphocytic leukemia | 21291569 | CNVD |
Colorectal cancer | 16774939 | CNVD |
Myelofibrosis | 22110671 | CNVD |
Lung adenocarcinoma | 17086460 | CNVD |
Immune disease | 21076436 | CNVD |
Immune disease | 21042300 | CNVD |
Lung cancer | 17086460 | CNVD |
Gastric cancer | 16891809 | CNVD |
Multiple myeloma | 17550852 | CNVD |
Non-syndromic sensorineural hearing loss | 22037309 | CNVD |
No. | Chromosome Location | Chromatin state | Cell line | Tissue |
---|---|---|---|---|
1 | chr1:104890600-104891400 | Enhancers | hESC Derived CD184+ Endoderm Cultured Cells | ES cell derived |
2 | chr1:104896000-104896400 | Enhancers | Primary hematopoietic stem cells G-CSF-mobilized Female | -- |
3 | chr1:104896200-104896600 | Enhancers | Primary hematopoietic stem cells G-CSF-mobilized Male | -- |
4 | chr1:104899200-104899400 | Enhancers | Foreskin Melanocyte Primary Cells skin03 | Skin |
5 | chr1:104899400-104900600 | Weak transcription | Foreskin Melanocyte Primary Cells skin03 | Skin |
6 | chr1:104900600-104903200 | Enhancers | Foreskin Melanocyte Primary Cells skin03 | Skin |
7 | chr1:104900800-104901000 | Enhancers | Foreskin Melanocyte Primary Cells skin01 | Skin |
8 | chr1:104901000-104901800 | Weak transcription | Foreskin Melanocyte Primary Cells skin01 | Skin |
9 | chr1:104901800-104903000 | Enhancers | Foreskin Melanocyte Primary Cells skin01 | Skin |
10 | chr1:104903200-104904200 | Weak transcription | Foreskin Melanocyte Primary Cells skin03 | Skin |
11 | chr1:104904200-104905000 | Enhancers | Foreskin Melanocyte Primary Cells skin03 | Skin |